KR100860703B1 - 뇌경색 예방 및 치료용 약제의 제조에서엘-부틸프탈라이드의 용도 - Google Patents
뇌경색 예방 및 치료용 약제의 제조에서엘-부틸프탈라이드의 용도 Download PDFInfo
- Publication number
- KR100860703B1 KR100860703B1 KR1020067006909A KR20067006909A KR100860703B1 KR 100860703 B1 KR100860703 B1 KR 100860703B1 KR 1020067006909 A KR1020067006909 A KR 1020067006909A KR 20067006909 A KR20067006909 A KR 20067006909A KR 100860703 B1 KR100860703 B1 KR 100860703B1
- Authority
- KR
- South Korea
- Prior art keywords
- nbp
- butylphthalide
- pharmaceutical composition
- cerebral infarction
- cerebral
- Prior art date
Links
- 0 *[C@@](c1ccccc11)OC1=O Chemical compound *[C@@](c1ccccc11)OC1=O 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
- C07D307/88—Benzo [c] furans; Hydrogenated benzo [c] furans with one oxygen atom directly attached in position 1 or 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Psychiatry (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Furan Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims (7)
- 청구항 1에 있어서, 상기 뇌경색은 국소뇌허혈(focal cerebral ischemia)에 의해 유발되는 것을 특징으로 하는, 뇌경색 예방 또는 치료용 약학적 조성물.
- 삭제
- 청구항 1에 있어서, 상기 약학적 조성물은 상기 화학식(Ⅰ)의 L-부틸프탈라이드를 0.1 ~ 95중량% 포함하는, 뇌경색 예방 또는 치료용 약학적 조성물.
- 청구항 1에 있어서, 상기 약학적 조성물은 정제, 캡슐, 환약, 주사, 서방형 제제, 방출제어형 제제, 및 여러 가지 미립자 전달 시스템을 포함하는, 뇌경색 예방 또는 치료용 약학적 조성물.
- 청구항 6에 있어서, 상기 뇌경색은 국소뇌허혈(focal cerebral ischemia)에 의해 유발되는 것을 특징으로 하는, 뇌경색 예방 또는 치료용 약학적 조성물을 제조하는 방법.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200310100222.2 | 2003-10-10 | ||
CNA2003101002222A CN1605336A (zh) | 2003-10-10 | 2003-10-10 | 左旋丁基苯酞在制备预防和治疗脑梗塞的药物中的应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20060085915A KR20060085915A (ko) | 2006-07-28 |
KR100860703B1 true KR100860703B1 (ko) | 2008-09-26 |
Family
ID=34427785
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020067006909A KR100860703B1 (ko) | 2003-10-10 | 2004-09-29 | 뇌경색 예방 및 치료용 약제의 제조에서엘-부틸프탈라이드의 용도 |
Country Status (10)
Country | Link |
---|---|
US (2) | US20070112065A1 (ko) |
EP (3) | EP2974722A1 (ko) |
JP (3) | JP2007507436A (ko) |
KR (1) | KR100860703B1 (ko) |
CN (3) | CN1605336A (ko) |
AU (1) | AU2004279655B2 (ko) |
BR (1) | BRPI0415123A (ko) |
CA (3) | CA2549931A1 (ko) |
RU (1) | RU2336870C2 (ko) |
WO (1) | WO2005034936A1 (ko) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1605336A (zh) | 2003-10-10 | 2005-04-13 | 中国医学科学院药物研究所 | 左旋丁基苯酞在制备预防和治疗脑梗塞的药物中的应用 |
CN101627992B (zh) * | 2004-01-20 | 2012-09-12 | 石药集团中奇制药技术(石家庄)有限公司 | 左旋丁苯酞在制备治疗脑卒中药物中的应用 |
CN1647796A (zh) * | 2004-01-20 | 2005-08-03 | 中奇制药技术(石家庄)有限公司 | 左旋丁苯酞在制备预防和治疗脑缺血疾病药物中的应用 |
US8552058B2 (en) | 2004-06-18 | 2013-10-08 | CSPC Zhongqi Pharmaceutical Technology (Shijazhuang) Co., Ltd. | Application of L-n-butylphthalide in preventing and treating dementia |
CN100367951C (zh) * | 2005-12-16 | 2008-02-13 | 石药集团恩必普药业有限公司 | 丁苯酞静脉乳剂及其应用 |
KR101659596B1 (ko) * | 2011-10-13 | 2016-09-23 | 쉬지아주앙 일링 파머서티컬 컴퍼니 리미티드 | 부틸프탈라이드 유도체 및 그의 제조방법 및 그의 용도 |
CN103356521A (zh) * | 2012-04-01 | 2013-10-23 | 石药集团恩必普药业有限公司 | 丁苯酞或其衍生物在制备治疗或预防放射性脑损伤的药物中的应用 |
CN103505414B (zh) * | 2012-06-28 | 2017-08-08 | 石药集团恩必普药业有限公司 | 丁苯酞滴鼻剂及其制备方法 |
CN103655555B (zh) | 2012-09-14 | 2018-08-28 | 中山大学 | 3-正丁基-异吲哚啉-1-酮在制备预防和治疗脑梗塞的药物中的应用 |
CN109939102B (zh) * | 2013-06-13 | 2022-05-17 | 石药集团中奇制药技术(石家庄)有限公司 | 一种包含丁苯酞和冰片的药物组合物及其应用 |
CN104721166A (zh) * | 2013-12-21 | 2015-06-24 | 石药集团恩必普药业有限公司 | 一种丁基苯酞液体硬胶囊制剂及其制备方法 |
CN104306372B (zh) * | 2014-11-10 | 2018-05-08 | 石药集团恩必普药业有限公司 | 一种丁苯酞制剂组合物及其制备方法与用途 |
KR101749410B1 (ko) | 2015-09-09 | 2017-06-21 | 충북대학교 산학협력단 | 불멸화 신경줄기세포를 유효성분으로 포함하는 뇌경색 또는 뇌졸중 예방 및 치료용 약제학적 조성물 |
CN108069942A (zh) * | 2016-11-10 | 2018-05-25 | 四川大学 | 苯酞吡唑酮类偶联物、其制备方法和用途 |
WO2021084559A1 (en) * | 2019-11-01 | 2021-05-06 | Celagenex Research (India) Pvt. Ltd. | Synergistic nutritional compositions for treating cerebrovascular diseases |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5733524A (en) * | 1984-03-19 | 1998-03-31 | The Picower Institute For Medical Research | Methods and materials for the diagnosis and treatment of conditions such as stroke |
JPH0798815B2 (ja) | 1986-09-29 | 1995-10-25 | 株式会社ツムラ | フタリド誘導体 |
US5744500A (en) * | 1990-01-03 | 1998-04-28 | Teva Pharmaceutical Industries, Ltd. | Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof |
ZA928276B (en) | 1991-10-31 | 1993-05-06 | Daiichi Seiyaku Co | Aromatic amidine derivates and salts thereof. |
CN1048158C (zh) * | 1993-09-09 | 2000-01-12 | 中国医学科学院药物研究所 | 芹菜甲素在制备预防和治疗哺乳动物或人类脑缺血引起的疾病的药中的应用 |
US6350739B1 (en) * | 1999-08-11 | 2002-02-26 | University Of Florida Resarch Foundation, Inc. | Methods of prevention and treatment of ischemic damage |
US5914112A (en) * | 1996-01-23 | 1999-06-22 | Genentech, Inc. | Anti-CD18 antibodies in stroke |
JP3866800B2 (ja) * | 1996-08-29 | 2007-01-10 | 東菱薬品工業株式会社 | アポトーシス関連疾患の予防及び/又は治療薬 |
CN1086942C (zh) * | 1998-12-18 | 2002-07-03 | 中国医学科学院药物研究所 | 丁基苯酞在制备抗血栓形成及抗血小板聚集药物中的应用 |
CN1136209C (zh) | 1999-07-05 | 2004-01-28 | 中国医学科学院药物研究所 | 制备光学活性3-正丁苯酞的方法 |
KR20010069066A (ko) * | 2000-01-12 | 2001-07-23 | 이종원 | 저산소 농도하에서 생존이 가능하도록 하는 동물세포의배양방법 |
ES2169986B1 (es) * | 2000-03-14 | 2003-06-16 | Ferrer Int | Uso de cdp-colina para el tratamiento profilactico de la isquemia cerebral. |
CN1443070A (zh) * | 2000-03-24 | 2003-09-17 | 苏坎波公司 | 包含15-酮基-前列腺素或其衍生物的编程性细胞死亡抑制组合物 |
CN1182127C (zh) * | 2000-06-28 | 2004-12-29 | 中国医学科学院药物研究所 | 新的取代的2-苯并[c]呋喃酮化合物,其制备方法以及包含它们的药物组合物 |
US6852687B2 (en) * | 2001-04-26 | 2005-02-08 | Kazuo Tsubota | Method for inhibiting apoptosis |
CN1166693C (zh) * | 2001-06-18 | 2004-09-15 | 中奇制药技术(石家庄)有限公司 | 丁苯酞环糊精或环糊精衍生物包合物及其制备方法和用途 |
US6447814B1 (en) * | 2001-08-28 | 2002-09-10 | Yung Shin Pharma Ind. Co. Ltd. | Chinese herbal composition for improving blood circulation and the method of preparing the same |
WO2003072543A2 (en) * | 2002-02-21 | 2003-09-04 | Quark Biotech, Inc. | Methods of preventing or treating brain ischemia or brain injury |
CN1375288A (zh) * | 2002-05-13 | 2002-10-23 | 周桂荣 | 一种治疗脑血管疾病的药物组合物 |
BR0215848A (pt) * | 2002-08-21 | 2005-06-21 | Shijiazhuang Pharma Group | Complexos de inclusão de butilfitalida com ciclodextrina ou seus derivados, processo para preparação destes e uso dos mesmos |
CN100562314C (zh) * | 2003-05-14 | 2009-11-25 | 帝斯曼知识产权资产管理有限公司 | 苯并呋喃酮衍生物用于治疗和预防糖尿病的用途 |
KR20060121887A (ko) * | 2003-09-23 | 2006-11-29 | 디에스엠 아이피 어셋츠 비.브이. | 진성 당뇨병의 치료 및 예방용 조성물 |
CN1605336A (zh) | 2003-10-10 | 2005-04-13 | 中国医学科学院药物研究所 | 左旋丁基苯酞在制备预防和治疗脑梗塞的药物中的应用 |
US7256198B2 (en) * | 2004-02-18 | 2007-08-14 | Wyeth | Pyrimidoindolones and methods for using same |
KR100700065B1 (ko) * | 2004-04-20 | 2007-03-27 | 신준식 | 신경보호작용을 가지는 생약 조성물 |
US7482027B2 (en) * | 2005-04-30 | 2009-01-27 | Angiolab, Inc. | Composition for the prevention or treatment of diseases associated with angiogenesis |
-
2003
- 2003-10-10 CN CNA2003101002222A patent/CN1605336A/zh active Pending
-
2004
- 2004-09-29 AU AU2004279655A patent/AU2004279655B2/en active Active
- 2004-09-29 RU RU2006115784/15A patent/RU2336870C2/ru active
- 2004-09-29 CA CA002549931A patent/CA2549931A1/en not_active Abandoned
- 2004-09-29 CN CN2010105412743A patent/CN102008464B/zh active Active
- 2004-09-29 CA CA3028912A patent/CA3028912A1/en not_active Abandoned
- 2004-09-29 CA CA2902337A patent/CA2902337A1/en not_active Abandoned
- 2004-09-29 EP EP15181920.8A patent/EP2974722A1/en not_active Ceased
- 2004-09-29 WO PCT/CN2004/001123 patent/WO2005034936A1/zh active Application Filing
- 2004-09-29 EP EP20130187375 patent/EP2689776A1/en not_active Withdrawn
- 2004-09-29 US US10/574,917 patent/US20070112065A1/en not_active Abandoned
- 2004-09-29 EP EP04762256A patent/EP1679070A4/en not_active Withdrawn
- 2004-09-29 JP JP2006529562A patent/JP2007507436A/ja active Pending
- 2004-09-29 KR KR1020067006909A patent/KR100860703B1/ko active IP Right Grant
- 2004-09-29 CN CNA2004800294090A patent/CN1863523A/zh active Pending
- 2004-09-29 BR BRPI0415123-2A patent/BRPI0415123A/pt not_active Application Discontinuation
-
2010
- 2010-10-20 US US12/908,520 patent/US8598225B2/en active Active
-
2011
- 2011-03-08 JP JP2011049876A patent/JP6027722B2/ja active Active
-
2014
- 2014-08-07 JP JP2014161400A patent/JP2014205724A/ja active Pending
Non-Patent Citations (1)
Title |
---|
Acta Pharmacologica Sinica, 2003, Vol.24, No.8, pp.796-804* |
Also Published As
Publication number | Publication date |
---|---|
BRPI0415123A (pt) | 2006-11-28 |
EP2974722A1 (en) | 2016-01-20 |
CA2549931A1 (en) | 2005-04-21 |
JP2011116781A (ja) | 2011-06-16 |
EP1679070A4 (en) | 2010-02-17 |
CN1863523A (zh) | 2006-11-15 |
CA2902337A1 (en) | 2005-04-21 |
CA3028912A1 (en) | 2005-04-21 |
AU2004279655A1 (en) | 2005-04-21 |
WO2005034936A1 (fr) | 2005-04-21 |
JP2014205724A (ja) | 2014-10-30 |
EP1679070A1 (en) | 2006-07-12 |
EP2689776A1 (en) | 2014-01-29 |
RU2336870C2 (ru) | 2008-10-27 |
CN1605336A (zh) | 2005-04-13 |
AU2004279655B2 (en) | 2008-09-25 |
CN102008464A (zh) | 2011-04-13 |
US20070112065A1 (en) | 2007-05-17 |
US20110082201A1 (en) | 2011-04-07 |
US8598225B2 (en) | 2013-12-03 |
CN102008464B (zh) | 2012-08-29 |
RU2006115784A (ru) | 2007-11-27 |
JP2007507436A (ja) | 2007-03-29 |
JP6027722B2 (ja) | 2016-11-16 |
KR20060085915A (ko) | 2006-07-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6027722B2 (ja) | 脳梗塞の予防及び治療用医薬品の製造におけるl−ブチルフタリドの使用 | |
EP0876143B1 (en) | Tumor necrosis factor alpha (tnf-alpha) inhibiting pharmaceuticals | |
US10329243B2 (en) | Biphenyl derivative and uses thereof | |
US4880833A (en) | Synergistic pharmaceutical compositions, their production and use | |
TWI747406B (zh) | 包含檸檬苦素類化合物和磺醯尿素類藥物的組合產品及其用途 | |
RU2625797C2 (ru) | Использование 3-n-бутил изоиндолин кетонов при приготовлении лекарственных средств для профилактики и лечения церебрального инфаркта | |
JP2872809B2 (ja) | モノシアロガングリオシドgm▲下1▼またはその誘導体を含有する,パーキンソン病の治療に適する医薬組成物 | |
TW201424746A (zh) | 用以治療腸激躁症之山薑屬植物萃取物 | |
CN114732826A (zh) | γ-氨基丁酸协同斯皮诺素在预防、缓解或治疗焦虑症中的应用 | |
WO2023280238A1 (zh) | 一种包含绿原酸的药物组合物在制备治疗早期阿尔茨海默病的药物中的用途 | |
FR2760364A1 (fr) | Utilisation de composes antiarythmiques pour reduire la mortalite apres infarctus du myocarde | |
CN108771662A (zh) | 紫檀芪在制备防治高尿酸肾病的药物中的用途 | |
US20240009133A1 (en) | Methods of treating autoimmune or inflammatory conditions with cannabidiol or its derivatives/analogs | |
EP0413694B1 (fr) | Preparations medicamenteuses cardio-protectrices comprenant l'amiodarone, un derive nitre, notamment le dinitrate d'isosorbide et facultativement un beta-bloqueur | |
WO2021027582A1 (zh) | 包含柠檬苦素类化合物和噻唑烷二酮类药物的组合产品 | |
TWI393562B (zh) | 左旋丁基苯酞在製備預防和治療腦梗塞的藥物中的應用 | |
CN114848639B (zh) | 玫瑰啶碱a在制备预防脑缺血药物或保健品中的应用 | |
JP7257091B2 (ja) | 認知症の治療及び予防薬 | |
KR100796005B1 (ko) | 시르시마린 또는 시르시마리틴을 함유하는 혈관 평활근이완용 조성물 | |
US20240122956A1 (en) | Application of Naringin Combined with Rapamycin in Preparation of Medications for Treating Hyperlipidemia | |
JPH0477426A (ja) | 血管平滑筋弛緩剤 | |
TWI527828B (zh) | 新穎的三萜化合物及其用途 | |
TW202010496A (zh) | 双那布扶林己二酸酯和乙醯胺酚的藥物製劑及治療疼痛的方法 | |
JPH01294621A (ja) | 幹細胞増殖促進剤 | |
JPH07165569A (ja) | 脳機能改善剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20120919 Year of fee payment: 5 |
|
FPAY | Annual fee payment |
Payment date: 20130903 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20140820 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20150825 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20170825 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20190826 Year of fee payment: 12 |